Market Overview

Artificial Insemination (Intrauterine, Intracervical, Intravaginal ) Market - Global Forecast to 2025 - ResearchAndMarkets.com

Share:

The "Artificial
Insemination Market Analysis By Type (Intrauterine Insemination,
Intracervical Insemination, Intravaginal Insemination), By End-use, By
Source Type, And Segment Forecasts, 2018 - 2025"
report has
been added to ResearchAndMarkets.com's offering.

The global artificial insemination market is expected to reach USD 2.63
billion by 2025

Over the past few years, infertility has become a major public health
concern across the globe. Artificial insemination is usually the
preferred first-line treatment for infertility. According to WHO, around
10% of women in the world are struggling to get pregnant. Lifestyle
changes, delay in pregnancy, and hormonal issues are some of the reasons
contributing to the rise in infertility around the world.

The exact estimation of infertility statistics is challenging, however,
WHO monitors its prevalence across the world. At present, 46% of the
global population lives in countries having low levels of fertility.
According to United Nations, the global rate of fertility is expected to
decline to 2.4 by 2030 and 2.2 by 2050. In developing or underdeveloped
nations, medical consultation regarding infertility and childlessness
was not easily accessible. Hence, there was lack of awareness about
available assisted reproductive techniques including artificial or donor
insemination and IVF.

Some of the key players in this market include Irvine Scientific;
Rinovum Women's Health, LLC; TenderNeeds Fertility; Conceivex, Inc.;
Hi-Tech Solutions; among others.

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Research Methodology

Chapter 3 Market Variables, Trends, & Scope

Chapter 4 Artificial Insemination: Type Estimates & Trend Analysis

Chapter 5 Artificial Insemination: End-use Estimates & Trend Analysis

Chapter 6 Artificial Insemination: Source Type Estimates & Trend Analysis

Chapter 7 Artificial Insemination: Regional Estimates & Trend Analysis

Chapter 8 Competitive Landscape

  • Vitrolife AB
  • Genea Limited
  • Rinovum Women's Health LLC
  • Pride Angel
  • Hi-Tech Solutions
  • Irvine Scientific
  • Kitazato
  • Rocket Medical PLC

For more information about this report visit https://www.researchandmarkets.com/research/w9htj5/artificial?w=4

View Comments and Join the Discussion!